Compare Liquidia Corporation Common Stock (LQDA) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Liquidia Corporation Common Stock trades at $34.27 (market cap $3.04B), while iShares 20 Plus Year Treasury Bond ETF trades at $80.02 (market cap $49.02B). The key difference: iShares 20 Plus Year Treasury Bond ETF is far larger — about 16.1× Liquidia Corporation Common Stock's market cap, and iShares 20 Plus Year Treasury Bond ETF is more actively traded (50,953,748 versus 21,111,778). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.
| LQDA | TLT | |
|---|---|---|
Market Cap | $3.04B | $49.02B |
Volume | 21,111,778 | 50,953,748 |
Sector | Health | Fixed Income |
52-Week High | $91.03 | $92.06 |
52-Week Low | $22.02 | $77.11 |
Typical Hold Time | 0 Days | 83 Days |
Enterprise Value | $2.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLT, the iShares 20+ Year Treasury Bond ETF, trades at $78.34 with a slight 0.37% daily gain amid a challenging bond market environment. Technical indicators show a bearish trend with moving averages and oscillators signaling selling pressure, while fundamental metrics remain unavailable for this bond ETF. The fund has declined significantly, down 11% year-to-date and 46% over five years as Treasury yields reach multi-decade highs.
The outlook remains pressured by rising interest rates and inflation concerns, though recent yield retreats offer potential stabilization. Key risks include continued Fed hawkishness and economic data surprises, while opportunities exist for long-term investors seeking yield at current levels. Market sentiment is cautious as investors weigh duration exposure against persistent inflation pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
